Navigation Links
Poniard Pharmaceuticals Announces Management Changes and Focus on Development and Commercialization of Picoplatin
Date:11/25/2008

in these forward-looking statements based on a number of factors, including risks and uncertainties associated with the Company's research and development activities; the results of pre-clinical and clinical testing; the receipt and timing of required regulatory approvals; the market's acceptance of the Company's proposed products; the Company's anticipated operating losses, need for future capital and ability to obtain future funding; competition from third parties; the Company's ability to preserve and protect intellectual property rights; the Company's dependence on third-party manufacturers and suppliers; the Company's lack of sales and marketing experience; the Company's ability to attract and retain key personnel; changes in technology, government regulation and general market conditions; and the risks and uncertainties described in the Company's current and periodic reports filed with the Securities and Exchange Commission (SEC), including the Company's Annual Report on Form 10-K for the year ended December 31, 2007 and its Quarterly Report on Form 10-Q for the period ended September 30, 2008. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this release. The Company undertakes no obligation to update any forward-looking statement to reflect new information, events or circumstances after the date of this release or to reflect the occurrence of unanticipated events.

(C) 2008 Poniard Pharmaceuticals, Inc. All Rights Reserved.

Poniard and Poniard Pharmaceuticals are trademarks of Poniard Pharmaceuticals, Inc.


'/>"/>
SOURCE Poniard Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Poniard Pharmaceuticals to Present Updated Results of Picoplatin Phase 2 Small Cell Lung Cancer Trial at 12th World Conference on Lung Cancer
2. Poniard Pharmaceuticals Announces Updated Results of Picoplatin Phase 2 Trial Demonstrating Survival Benefit in Small Cell Lung Cancer Patients
3. Poniard Pharmaceuticals Receives FDA Fast Track Designation for Picoplatin for Treatment of Small Cell Lung Cancer
4. Poniard Pharmaceuticals Initiates Randomized Phase 2 Trial of Picoplatin for First-Line Treatment of Metastatic Colorectal Cancer
5. Poniard Pharmaceuticals Provides Year-End Clinical Update at 2007 Lazard Capital Markets Healthcare Conference
6. Poniard Pharmaceuticals Announces Picoplatin Safety Data in Colorectal Cancer
7. Poniard Pharmaceuticals Announces Positive First-line Phase 1 Safety and Efficacy Data With Picoplatin in Metastatic Prostate Cancer Patients
8. Poniard Pharmaceuticals Announces Clinical Data From Picoplatin Oral Phase 1 to Be Presented at the American Association of Cancer Research Annual Meeting
9. Poniard Pharmaceuticals Announces Commercial Manufacturing Agreement With W. C. Heraeus GmbH for Picoplatin
10. Poniard Pharmaceuticals Announces Presentation of Clinical Data From Picoplatin Phase 2 Small Cell Lung Cancer Trial to be Presented at 1st IASLC-ESMO European Lung Cancer Conference
11. Poniard Pharmaceuticals Oral Picoplatin Demonstrates Positive Bioavailability in Ongoing Phase 1 Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... JORDAN, Utah , July 10, 2014  BC ... solutions, and MiE America , Inc., a leading ... have entered into a long-term agreement naming BC Technical ... the US. MiE and BC Technical ... strategic agreement to establish BC Technical as the service ...
(Date:7/10/2014)... July 10, 2014 CVS Caremark Corporation (NYSE: ... has approved a quarterly dividend of $0.275 (27.5 cents) per ... on August 1, 2014, to holders of record on July ... CVS Caremark is dedicated to helping people on their path ... the United States . Through the company,s ...
(Date:1/15/2014)... DUBLIN , Jan. 15, 2014  Research and Markets ... "Dental Consumables Market - Global Industry Analysis, Size, ... report to their offering. (Logo: ... products which are used on patients in order to ...
Breaking Medicine Technology:BC Technical Partners With MiE America To Be Authorized Provider Of Systems & Service 2Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 2Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 3
... LITTLE FALLS, N.J., March 3, 2011 Cantel Medical Corp. ... its second quarter ended January 31, 2011 on Wednesday, March ... to discuss the results at 11:00 AM ET. Participating in ... Krakauer, President and CEO; Seth R. Segel, Executive Vice President; ...
... ConvaTec Healthcare, a world-leading developer, manufacturer and marketer of ... announced that, recognizing favorable conditions in the credit markets, ... a portion of its senior secured term loans originally ... While the year-end audit process is ongoing, ConvaTec presently ...
Cached Medicine Technology:Cantel Medical Corp. to Hold Conference Call to Discuss Results for Its Second Quarter Ended January 31, 2011 2ConvaTec Healthcare Announces Plans to Refinance Secured Term Loans 2ConvaTec Healthcare Announces Plans to Refinance Secured Term Loans 3
(Date:7/14/2014)... Love Digits LLC has successfully launched ... The App brings ancient astrology to the modern dating ... compatibility using a five-star rating system. By entering their ... test their compatibility for love and marriage across seven ... five-star rating system generates a weighted average of the ...
(Date:7/14/2014)... Spine Team Texas continues to ... to treatment and recovery. Currently all physical therapists at ... training for certification in The McKenzie Method. Two therapists, ... extensive program. , “We require certification of our therapists ... better outcomes for spine pain patients,” said Mark Hood, ...
(Date:7/14/2014)... WA (PRWEB) July 14, 2014 ... solutions, today announced its new IBM i (AS/400, ... Software Vendors (ISVs). As security threats evolve and ... software providers struggle to modernize their applications and ... program now makes it easy for ISVs on ...
(Date:7/14/2014)... Crystal Dental has recently announced that ... has been made via LAD Solutions in in order to ... been made in order to draw in new patients that ... , Crystal Dental offers a variety of services for both ... Crystal Dental include cosmetic dentistry procedures such as porcelain veneers ...
(Date:7/13/2014)... July 14, 2014 Save the Date for ... Hospital in Jacksonville, FL , BOXWOODS & BowTies “A Modern ... , Who: The Women’s Board of Wolfson Children’s Hospital ... Show to continue their ongoing commitment to raising funds ... children. , What: The 2014 Art & Antiques Show ...
Breaking Medicine News(10 mins):Health News:Love Digits, Numerical Approach to Modern Love, Now Available on iTunes 2Health News:Love Digits, Numerical Approach to Modern Love, Now Available on iTunes 3Health News:Spine Team Texas’ Physical Therapists Complete The McKenzie Method Training and Certification 2Health News:Spine Team Texas’ Physical Therapists Complete The McKenzie Method Training and Certification 3Health News:IBM i ISVs Can Now Easily Integrate Mobile-Based Two Factor Authentication to Increase Security of Solutions 2Health News:IBM i ISVs Can Now Easily Integrate Mobile-Based Two Factor Authentication to Increase Security of Solutions 3Health News:Crystal Dental Announces the Opening of New Office Location in Sacramento 2Health News:Save the Date for the 2014 Art & Antiques Show benefiting Wolfson Children's Hospital in Jacksonville, FL 2Health News:Save the Date for the 2014 Art & Antiques Show benefiting Wolfson Children's Hospital in Jacksonville, FL 3Health News:Save the Date for the 2014 Art & Antiques Show benefiting Wolfson Children's Hospital in Jacksonville, FL 4Health News:Save the Date for the 2014 Art & Antiques Show benefiting Wolfson Children's Hospital in Jacksonville, FL 5Health News:Save the Date for the 2014 Art & Antiques Show benefiting Wolfson Children's Hospital in Jacksonville, FL 6Health News:Save the Date for the 2014 Art & Antiques Show benefiting Wolfson Children's Hospital in Jacksonville, FL 7Health News:Save the Date for the 2014 Art & Antiques Show benefiting Wolfson Children's Hospital in Jacksonville, FL 8Health News:Save the Date for the 2014 Art & Antiques Show benefiting Wolfson Children's Hospital in Jacksonville, FL 9
... of Pennsylvania School of Veterinary Medicine have demonstrated ... attacks the cellular machinery, disrupts normal cellular function ... identified for the first time that mitochondria, the ... cellular fuel, are the target of tetrachlorodibenzodioxin, or ...
... insurance status are associated with survival rates among patients ... the December issue of Archives of OtolaryngologyHead & Neck ... U.S. men and women each year are diagnosed with ... background information in the article. For many years, total ...
... the industry,s technology leader in end-to-end bill cycle ... ... Workers, Compensation Payers, CONCORD, Calif., Dec. ... in providing catastrophic and complex,medical management services has entered ...
... DETROIT, Dec. 17 With much of the state experiencing,one ... more on,the horizon, Blue Cross Blue Shield of Michigan and ... mind and go slow,when clearing snow from driveways and sidewalks ... * Shoveling snow ...
... and Lab Accreditation ... ... Quality and Compliance Management Software, announced today that,it has donated over ... whose mission is to improve lives,worldwide through research, education, and services ...
... offers a critical appraisal of published research exploring the benefits of patients adhering to each of ... healthy eating habits , ... glucose monitoring , medication compliance ... healthful coping , ...
Cached Medicine News:Health News:Agent orange chemical, dioxin, attacks the mitochondria to cause cancer, says Penn research team 2Health News:Study examines factors associated with survival in advanced laryngeal cancer 2Health News:Paradigm Selects Jopari to Provide E-Billing Gateway for Customers 2Health News:Paradigm Selects Jopari to Provide E-Billing Gateway for Customers 3Health News:Blue Cross Blue Shield of Michigan Says Don't Let Snow Be a Pain: Ease into Clearing Sidewalks, Drives 2Health News:Blue Cross Blue Shield of Michigan Says Don't Let Snow Be a Pain: Ease into Clearing Sidewalks, Drives 3Health News:IQS Donates Quality Management Software to Family Health International 2Health News:IQS Donates Quality Management Software to Family Health International 3
... Borrelia (Lyme) test is an ... for the qualitative detection of ... and related Borrelia burgdorferi antibodies ... detected in serum as an ...
... Tests are qualitative enzyme immunoassays (EIA) for ... (IgG or IgM, respectively) in serum. Equivocal ... be supplemented with a standardized western blot ... to support a clinical diagnosis of B. ...
... dot-blot assay system combining microwell EIA and ... antigen set at a clinically meaningful cutoff ... detected using the same reagent system used ... antigens detected in Auto 4 detecting the ...
... The ImmunoWELL Cardiolipin Antibody (IgM) ... (EIA) for the quantitative detection ... in serum and is used ... the risk of thrombosis in ...
Medicine Products: